GILEAD SCIENCES, INC. bought ASMB
June 17, 2024 · Form 4 insider transaction
GILEAD SCIENCES, INC. bought 179,500 shares of Assembly Biosciences, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
179,500
Price
N/A
Total value
N/A
InsiderGILEAD SCIENCES, INC.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 17, 2024
Filing dateJune 20, 2024
Shares owned after1,268,972
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant.